The US Bankruptcy Court approved the third amended plan of reorganization of Amyris, Inc. on February 7, 2024. The debtor has filed its third amended plan in the Court on January 22, 2024. As per the amended plan, administrative claims of $75 million, DIP facility claims, professional fee claims, priority tax claims of $2.10 million, statutory fees, Ad Hoc group restructuring expenses, Ad Hoc cross-holder group restructuring expenses, Other secured claims and other priority claims of $0, shall be paid in full in cash.

Foris prepetition secured claims of $312.10 million shall receive pro rata share of cash. DSM RealSweet secured claim of $29.52 million shall receive DSM plan promissory note, if DSM votes to accept the plan and the DSM term sheet is implemented in full. If DSM votes to reject the Plan or DSM votes to accept the plan but the DSM term sheet is not implemented in full, then DSM will receive in full and complete satisfaction of its allowed DSM RealSweet secured claim, payment in cash on the effective date.

DSM other secured claims of $45.45 million will not receive any distribution under the plan. Lavvan secured claim shall receive the Lavvan Settlement Consideration i.e., cash in the amount of $15.14 million, in accordance with the Lavvan Settlement Agreement. Convertible note claims of $690 million shall receive a pro rata distribution of the creditor trust interests.

General unsecured claims of $200 million pro rata distribution of the creditor trust interests. DSM contract claims and Givaudan contract claims are estimated to be in the amount of $0. Intercompany claims and intercompany interests shall be reinstated. Section 510(b) claims shall not receive any payment under the plan.

Amyris equity interests shall be extinguished, and holders of such equity interests will not receive any distribution on account of such equity interests. The plan shall be funded through cash, sale of assets, new common stock, proceeds from the exit first lien facility.